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CHROMED: Clinical trial of elderly 




















• Bolnisnica Sežana Zavod, Slovenia (32 
patients)
Technical Centres

































































Assessed for eligibility (n = 326)
Excluded:
Declined to participate (n=14)
Analysed (n = 154)
Excluded from analysis, n=0
Lost to follow-up (patients with less than 9
months of monitoring, n = 45):
Death (n=3)
Hospitalized (n=8)
Difficulties in using the equipment (n=3)
Technical problem (n=4)
Personal problem/no reason provided (n=27)
Allocated to intervention (n = 154)
Lost to follow-up (patients with less than 9
months of monitoring, n = 36)
Death (n=4)
Hospitalized (n=7)
Difficulties in using the equipment (n=0)
Technical problem (n=0)
Personal problem/no reason provided (n=24)
Allocated to control (n = 158)
Analysed (n = 158)      








Sex (male/female) 101/53 105/53
Age (years) 71 71
Pack years 40 40.5
FEV1 (L/% predicted) 1.3 (49.4%) 1.3 (50.4%)
FEV1/FVC 0.5 0.51
SGRQ 46.2 50.9




































Monitored (n=154) Control (n=158) p value
Hospitalisation overall 79 103 ns
Respiratory 45 59 ns
Cardiac 7 5 ns
Days in hospital 329 650 ns
Respiratory 256 543 ns
Cardiac 45 18 ns
Monitor Control p value
Baseline 0.64 0.66 ns
3 months 0.66 0.63 ns
6 months 0.64 0.68 ns





















Hospitalizations 4,700.00€   (10312) 1,968.00€   (5034)
ED presentation 84.00€         (170) 35.00€         (84)
Early discharge 37.00€         (205) 18.00€         (138)
Hospital‐at‐home 32.00€         (146) ‐€              0
Outpatient visti 277.00€       (492) 310.00€       (570)
Ambulance 128.00€       (314) 148.00€       (511)
Primary care
GP office 690.00€       (949) 659.00€       (852)
District nurse 736.00€       (1033) 745.00€       (944)
Specialist nurse 96.00€         (423) 28.00€         (144)
Physiotherapist 123.00€       (451) 81.00€         (243)
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Additional slides
Alerts
 793 respiratory alerts = 
median (IQR) 0.55 (0.27‐
0.87) alerts/patient/month
 647 ‘clustered’ (worsening) 
respiratory alerts = median 
(IQR) 0.53 (0.29‐0.66) 
alerts/patient/month
 50% of alerts associated 
with a change in  at least 
one symptom
 222/647 (34%) required 
intervention after 
telephone discussion
 Symptoms
 Breathlessness 22%
 Cough 14%
 Change in phlegm 14%
 Sore throat or ‘cold’ 14%
 Less energy 12%
 Worse sleep 6%
 Wheeze 5%
 Treatment
 Change in current treatment 29%
 Addition of treatment 18%
 Visit by doctor or nurse 34%
 Hospitalisation 3%
 Suggested treatment refused 9%
Drop Out
• By the end of the 
study drop out was:
• 45 (29%) in monitored 
arm
• 36 (23%) in control 
arm
• This did not differ 
significantly between 
groups
